Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. J. Sexton, G. Chen, D. Martik, C. Pazmany, S. Hogan, J. Jacques, R. C. Ladner, T. Arulanandam, A. E. Nixon, C. R. Wood, W. M. Abraham (Cambridge, Miami Beach, United States Of America). Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness. Eur Respir J 2006; 28: Suppl. 50, 4376

Member's Comments

No comment yet.

Related content which might interest you: Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Source: Eur Respir J 2004; 24: 391-396 Year: 2004 The role of small airways in obstructive airway diseases Source: Eur Respir Rev 2011; 20: 23-33 Year: 2011 Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Smoking effect on airways inflammation in asthma and COPD: relationship with airways reversibility and hyperresponsiveness Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Small airways and hyperresponsiveness in asthma and COPD Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics Year: 2017 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004 IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004